COMPARISON OF HEALTH CARE UTILIZATION AND COSTS FOR PATIENTS WITH ASTHMA BY SEVERITY AND HEALTH INSURANCE IN THAILAND- USING GENERALIZED LINEAR REGRESSION MODEL
Author(s)
Dilokthornsakul P1, Lee TA2, Dhippayom T3, Jeanpeerapong N4, Chaiyakunapruk N5
1Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand, 2University of Illinois at Chicago, Chicago, IL, USA, 3Naresuan University, Muang, Phitsanulok, Thailand, 4Buddhachinaraj Hospital, Muang, Thailand, 5Monash University Malaysia, Selangor, Malaysia
OBJECTIVES: Asthma is a major healthcare problem. Understanding current patterns of healthcare utilization is important. Several previous studies compared healthcare utilization and cost by severity and health insurance; however, they may not be applicable to Thailand. This study aimed to compare healthcare utilization and cost by asthma severity and type of health insurance in Thailand. METHODS: A retrospective study using an electronic database was conducted in patients with asthma who visited a University-affiliated hospital during 2009-2011. The outcomes were healthcare utilization and costs of in-patient and out-patient care. We compared outcomes between groups based on a proxy of severity (high vs. non-high risk of emergency department visit) and type of health insurance. Multivariable generalized linear regression model with log link function was used to determine the difference of average healthcare cost, while multivariable negative binomial regression model was used to determine difference of the number of hospitalization among groups of severity and health insurance. Costs were converted to $US using 30.59 Thai-baht per $1US. RESULTS: Among 1,982 patients included, the average age was 40.3±24.0 years with 60.7% male. A total of 1,936 patients were non-high risk patients, while 46 patients were high-risk patients. There were 1,293 patients under universal coverage schemes (UCS), 264 patients under social security schemes, and 626 patients under civil servant medical benefit schemes (CSMBS). The average annual cost/patient was $598±871. In adjusted analyses, the healthcare cost of high-risk patients was $67 higher than that of non-high risk patients (95% confidence interval (CI); $64–$69). The cost of patients under CSMBS was $109 (95%CI; $105-$113) higher than that of patients under UCS. CONCLUSIONS: The healthcare costs in a cohort of patients with asthma were substantial and were higher in high-risk patients and patients under CSMBS.
Conference/Value in Health Info
2014-09, ISPOR Asia Pacific 2014, Beijing, China
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PRS12
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Respiratory-Related Disorders